Aquilant, part of Healthcare 21 UK, is pleased to announce a new partnership with Stereotaxis to bring its industry-leading Robotic Magnetic Navigation (RMN) technology to the UK.
Through this collaboration, Aquilant will introduce the Genesis RMN and GenesisX systems. These are advanced robotic technologies designed to support greater precision, improved workflow and broader access to complex electrophysiology procedures.
The Genesis RMN system uses magnets that rotate around their centre of mass, enabling highly responsive physician control. Mounted on flexible, durable robotic arms, the system offers an expanded range of motion. This allows wider X-ray angulation and creates a strong platform for future innovation.
GenesisX has been designed with built-in magnetic shielding, helping ensure the lab environment can support both robotic and non-robotic procedures. Its semi-mobile design allows the system to move away from the patient table. It improves access for clinicians and supports a more flexible working environment for the full lab team.
This partnership marks an important step in strengthening Aquilant’s cardiac portfolio. It also reflects our continued commitment to bringing innovative, clinically meaningful technologies to healthcare providers across the UK.
We look forward to working closely with Stereotaxis to support the future of cardiac electrophysiology and help bring these advanced solutions to more patients and clinical
United Kingdom
Ireland